Baylor Miraca Genetics Laboratories
The Medical Genetic Multiomics Laboratory recently launched its first diagnostic test, a whole-transcriptome RNA-seq assay, commercialized by Baylor Genetics.
Baylor Genetics, Baylor College of Medicine Launch Joint Diagnostics Lab Venture
The new lab has also launched a transcriptomic sequencing test aimed at identifying disease-causing genes from blood and skin cells.
Baylor Genetics Machine Learning Tool Shows Promise for Clinical Rare Variant Interpretation
Premium
AI-MARRVEL also showed potential for disease gene discovery by correctly predicting two disease genes recently reported by the Undiagnosed Diseases Network.
Baylor Genetics, SRL Ink Clinical Sequencing Tech Transfer Agreement
Under the agreement, Baylor Genetics will transfer its clinical-grade whole-genome and whole-exome sequencing technology to SRL beginning in 2022.
Aspira Collaborating With Baylor Genetics on Ovarian Cancer Early Detection Test
Aspira said it will bring its experience in patient sample recruitment and ovarian cancer assay development to the collaboration.